Ligand validation:2X9M

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 2X9M designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2X9M_NAG_A_1605	68%	59%	0.138	0.949	0.56	0.99	-	1	0	0	100%	0.9333
2X9M_NAG_B_1604	67%	61%	0.131	0.94	0.43	1.03	-	1	0	0	100%	0.9333
2X9M_NAG_A_1604	52%	40%	0.16	0.919	0.65	1.73	-	3	2	0	100%	0.9333
2X9M_NAG_B_1605	50%	58%	0.172	0.924	0.51	1.06	-	1	0	0	100%	0.9333
2X9M_NAG_A_1606	36%	47%	0.214	0.908	0.69	1.36	-	4	0	0	100%	0.9333
2X9M_NAG_D_1604	29%	62%	0.251	0.91	0.5	0.92	-	-	0	0	100%	0.9333
2X9M_NAG_B_1607	26%	58%	0.253	0.894	0.61	0.97	-	2	0	0	100%	0.9333
2X9M_NAG_B_1606	22%	59%	0.205	0.817	0.54	1	-	1	0	0	100%	0.9333
2X9M_NAG_C_1604	20%	49%	0.25	0.849	0.47	1.47	-	3	0	0	100%	0.9333
2X9M_NAG_A_1607	14%	54%	0.285	0.837	0.55	1.23	-	1	0	0	100%	0.9333
6PD4_NAG_A_705	29%	74%	0.21	0.869	0.3	0.69	-	1	0	0	100%	0.9333
6PDL_NAG_C_701	23%	65%	0.251	0.872	0.68	0.66	1	1	0	0	100%	0.9333
6CMG_NAG_A_703	2%	70%	0.392	0.665	0.39	0.73	-	1	0	0	100%	0.9333
6CMI_NAG_B_703	1%	69%	0.291	0.514	0.37	0.78	-	1	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.